Ammar Asban
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ammar Asban has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Herbert Chen
Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA
5 shared publications Reema Mallick
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
2 shared publicationsRongbing Xie
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
2 shared publications- Abhishek Chatterjee
Department of Surgery, Tufts Medical Center, Boston, MA, USA.
1 shared publication Ashley Anue
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
1 shared publicationAshley Aune
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
1 shared publication
Latest Publications
- 27 May 2020
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 58 (4) , 682-691
Mechanical or chemical and mechanical pleurodesis for spontaneous pneumothorax: what is the most effective approach in preventing recurrence? A systematic review and meta-analysis
OBJECTIVES: Surgical management of spontaneous pneumothorax typically involves wedge resection and mechanical pleurodesis. It is unclear whether combining mechanical and chemical pleurodesis can further reduce the recurrence rate. We have performed a meta-analysis of studies comparing the combined approach with mechanical pleurodesis alone. METHODS: A comprehensive search of the existing literature was performed using PubMed, EMBASE and Web of Science for all types of studies that compared combined pleurodesis to a single approach. We used the Cochrane Risk of Bias Tool and Strengthening The Reporting of OBservational Studies in Epidemiology (STROBE) to assess the quality of the studies. Relative risk of pneumothorax recurrence was calculated, and the differences between the studies were examined. The primary outcome was the recurrence of pneumothorax. RESULTS: Of 2301 eligible studies, 5 studies were included. Five hundred sixty-one patients who received combined pleurodesis were compared to 286 patients who received mechanical pleurodesis only. Patients treated with combined intervention had a 63% lower risk of developing a recurrent pneumothorax compared to single intervention [relative risk 0.37, 95% confidence interval (CI) 0.18–0.76; P = 0.006]. There were no statistically significant differences in the length of stay (standardized mean difference −0.17, 95% CI −0.39 to 0.05, P = 0.138), the duration of postoperative air leak (standardized mean difference 0.17, 95% CI −1.14 to 1.47, P = 0.804) or the duration of postoperative chest tube drainage (standardized mean difference −0.07, 95% CI −0.27 to 0.12, P = 0.471). CONCLUSIONS: This meta-analysis demonstrated that combined intervention with mechanical and chemical pleurodesis for spontaneous pneumothorax may be more effective in preventing recurrence than mechanical pleurodesis alone. These findings will provide some guidance to surgeons in the decision-making process.
- 27 May 2020
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 58 (4) , 682-691
Mechanical or chemical and mechanical pleurodesis for spontaneous pneumothorax: what is the most effective approach in preventing recurrence? A systematic review and meta-analysis
OBJECTIVES: Surgical management of spontaneous pneumothorax typically involves wedge resection and mechanical pleurodesis. It is unclear whether combining mechanical and chemical pleurodesis can further reduce the recurrence rate. We have performed a meta-analysis of studies comparing the combined approach with mechanical pleurodesis alone. METHODS: A comprehensive search of the existing literature was performed using PubMed, EMBASE and Web of Science for all types of studies that compared combined pleurodesis to a single approach. We used the Cochrane Risk of Bias Tool and Strengthening The Reporting of OBservational Studies in Epidemiology (STROBE) to assess the quality of the studies. Relative risk of pneumothorax recurrence was calculated, and the differences between the studies were examined. The primary outcome was the recurrence of pneumothorax. RESULTS: Of 2301 eligible studies, 5 studies were included. Five hundred sixty-one patients who received combined pleurodesis were compared to 286 patients who received mechanical pleurodesis only. Patients treated with combined intervention had a 63% lower risk of developing a recurrent pneumothorax compared to single intervention [relative risk 0.37, 95% confidence interval (CI) 0.18–0.76; P = 0.006]. There were no statistically significant differences in the length of stay (standardized mean difference −0.17, 95% CI −0.39 to 0.05, P = 0.138), the duration of postoperative air leak (standardized mean difference 0.17, 95% CI −1.14 to 1.47, P = 0.804) or the duration of postoperative chest tube drainage (standardized mean difference −0.07, 95% CI −0.27 to 0.12, P = 0.471). CONCLUSIONS: This meta-analysis demonstrated that combined intervention with mechanical and chemical pleurodesis for spontaneous pneumothorax may be more effective in preventing recurrence than mechanical pleurodesis alone. These findings will provide some guidance to surgeons in the decision-making process.
- 1 February 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 246, 435-441
Increasing Use of Thyroidectomy as Definitive Treatment for Hyperthyroidism
- 1 February 2020
- Published by Elsevier in Journal of Surgical Research
- Vol. 246, 435-441
Increasing Use of Thyroidectomy as Definitive Treatment for Hyperthyroidism
- 1 December 2019
- Published by Elsevier in Journal of Surgical Research
- Vol. 244, 348-351
What Does the Average Person Know About Endocrine and Vascular Surgeons?
- 1 December 2019
- Published by Elsevier in Journal of Surgical Research
- Vol. 244, 348-351
What Does the Average Person Know About Endocrine and Vascular Surgeons?
- 1 September 2019
- Published by Elsevier in The American Journal of Surgery
- Vol. 218 (3) , 597-604
A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer
- 1 September 2019
- Published by Elsevier in The American Journal of Surgery
- Vol. 218 (3) , 597-604
A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer
- Open Access
- 1 January 2019
- Published by SAGE Publications in Clinical Medicine Insights: Endocrinology and Diabetes
- Vol. 12
Gender and Racial Disparities in Survival After Surgery Among Papillary and Patients With Follicular Thyroid Cancer: A 45-Year Experience
Demographic disparities have been described for survival after thyroid cancer surgery using national registries and databases. At the institution level, we hypothesized that assessing survival after thyroid cancer surgery in a long-term cohort with diverse gender and racial groups would reveal disparities in survival. We examined medical records of patients with papillary or follicular thyroid cancer undergoing thyroidectomy, lobectomy, and other surgical procedures from 1971 to 2016 at a tertiary referral center. We obtained information on demographics, cancer stage, procedure, and radioactive iodine (RAI). We measured survival using Kaplan-Meier estimates and Cox proportional hazards models. A total of 1440 (91%) patients with papillary cancer and 144 (9%) patients with follicular thyroid cancer underwent total thyroidectomy (1297, 82%), lobectomy (261, 16.5%), and other surgical procedures (26, 1.5%). Most patients (1131, 71%) were woman, and 909 (57%) were older than 45 years. Race/ethnicity included 805 (51%) white, 161 (10%) African Americans, and 618 (39%) other race/ethnicities. Both 10- and 20-year survival rates in nonwhite males were worse compared with nonwhite females (P < .0001). After controlling for age, cancer type, stage, surgical procedure, RAI, and year of surgery, nonwhite males had a higher mortality risk compared with nonwhite females (P = .0376, confidence interval (CI): 1.03-2.43), white males (P < .0001, CI: 1.88-6.54), and white females (P < .0001, CI: 3.31-9.90). Our diverse cohort demonstrates significant gender and racial disparities in survival after thyroid cancer surgery. To improve health outcomes and reduce health disparities among nonwhite males, interventions and long-term care management should target potentially modifiable causes of worse outcomes in this group.
- 1 January 2019
- Published by SAGE Publications in Clinical Medicine Insights: Endocrinology and Diabetes
- Vol. 12
Open AccessGender and Racial Disparities in Survival After Surgery Among Papillary and Patients With Follicular Thyroid Cancer: A 45-Year Experience
Demographic disparities have been described for survival after thyroid cancer surgery using national registries and databases. At the institution level, we hypothesized that assessing survival after thyroid cancer surgery in a long-term cohort with diverse gender and racial groups would reveal disparities in survival. We examined medical records of patients with papillary or follicular thyroid cancer undergoing thyroidectomy, lobectomy, and other surgical procedures from 1971 to 2016 at a tertiary referral center. We obtained information on demographics, cancer stage, procedure, and radioactive iodine (RAI). We measured survival using Kaplan-Meier estimates and Cox proportional hazards models. A total of 1440 (91%) patients with papillary cancer and 144 (9%) patients with follicular thyroid cancer underwent total thyroidectomy (1297, 82%), lobectomy (261, 16.5%), and other surgical procedures (26, 1.5%). Most patients (1131, 71%) were woman, and 909 (57%) were older than 45 years. Race/ethnicity included 805 (51%) white, 161 (10%) African Americans, and 618 (39%) other race/ethnicities. Both 10- and 20-year survival rates in nonwhite males were worse compared with nonwhite females (P < .0001). After controlling for age, cancer type, stage, surgical procedure, RAI, and year of surgery, nonwhite males had a higher mortality risk compared with nonwhite females (P = .0376, confidence interval (CI): 1.03-2.43), white males (P < .0001, CI: 1.88-6.54), and white females (P < .0001, CI: 3.31-9.90). Our diverse cohort demonstrates significant gender and racial disparities in survival after thyroid cancer surgery. To improve health outcomes and reduce health disparities among nonwhite males, interventions and long-term care management should target potentially modifiable causes of worse outcomes in this group.
- Open Access
- 1 January 2019
- Published by SAGE Publications in Clinical Medicine Insights: Endocrinology and Diabetes
- Vol. 12
Considerations for Thyroidectomy as Treatment for Graves Disease
Hyperthyroidism is a clinical state that results from abnormally elevated thyroid hormones. Thyroid gland affects many organ systems; therefore, patients usually present with multiple clinical manifestations that involve many organ systems such as the nervous, cardiovascular, muscular, and endocrine system as well as skin manifestations. Hyperthyroidism is most commonly caused by Graves disease, which is caused by autoantibodies to the thyrotropin receptor (TRAb). Other causes of hyperthyroidism include toxic multinodular goiter, toxic single adenoma, and thyroiditis. Diagnosis of hyperthyroidism can be established by measurement of thyroid-stimulating hormone (TSH), which will be suppressed with either elevated free T4 and/or T3 (overt hyperthyroidism) or normal free T3 and T4 (subclinical hyperthyroidism). Hyperthyroidism can be treated with antithyroid drugs (ATDs), radioactive iodine (RAI), or thyroidectomy. ATDs have a higher replacement rate when compared with RAI or thyroidectomy. Recent evidence has shown that thyroidectomy is a very effective, safe treatment modality for hyperthyroidism and can be performed as an outpatient procedure. This review article provides some of the most recent evidence on diagnosing and treating patients with hyperthyroidism.
- 1 January 2019
- Published by SAGE Publications in Clinical Medicine Insights: Endocrinology and Diabetes
- Vol. 12
Open AccessConsiderations for Thyroidectomy as Treatment for Graves Disease
Hyperthyroidism is a clinical state that results from abnormally elevated thyroid hormones. Thyroid gland affects many organ systems; therefore, patients usually present with multiple clinical manifestations that involve many organ systems such as the nervous, cardiovascular, muscular, and endocrine system as well as skin manifestations. Hyperthyroidism is most commonly caused by Graves disease, which is caused by autoantibodies to the thyrotropin receptor (TRAb). Other causes of hyperthyroidism include toxic multinodular goiter, toxic single adenoma, and thyroiditis. Diagnosis of hyperthyroidism can be established by measurement of thyroid-stimulating hormone (TSH), which will be suppressed with either elevated free T4 and/or T3 (overt hyperthyroidism) or normal free T3 and T4 (subclinical hyperthyroidism). Hyperthyroidism can be treated with antithyroid drugs (ATDs), radioactive iodine (RAI), or thyroidectomy. ATDs have a higher replacement rate when compared with RAI or thyroidectomy. Recent evidence has shown that thyroidectomy is a very effective, safe treatment modality for hyperthyroidism and can be performed as an outpatient procedure. This review article provides some of the most recent evidence on diagnosing and treating patients with hyperthyroidism.
- 1 November 2018
- Published by Elsevier in The American Journal of Surgery
- Vol. 216 (5) , 985-989
To admit or not to admit? Experience with outpatient thyroidectomy for Graves’ disease in a high-volume tertiary care center
- 1 November 2018
- Published by Elsevier in The American Journal of Surgery
- Vol. 216 (5) , 985-989
To admit or not to admit? Experience with outpatient thyroidectomy for Graves’ disease in a high-volume tertiary care center
- 8 January 2018
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (6) , 1217-1222
Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15‐year experience in a high‐volume tertiary referral center
Background and Objectives: Genetic testing for pheochromocytoma and paraganglioma allows for early detection of hereditary syndromes and enables close follow‐up of high‐risk patient. We investigated the trends in genetic testing among patients at a high‐volume referral center and evaluated the prevalence of pheochromocytomas and paragangliomas.Methods: We reviewed the charts of 129 patients who underwent adrenalectomy for pheochromocytoma and paraganglioma between January 2000 and July 2015. To evaluate for trends in genetic testing, patients were divided by year of diagnosis: 2000‐2005 (group 1, n = 35), 2006‐2010 (group 2, n = 44), and 2011‐2015 (group 3, n = 50).Results: Among 129 patients the mean age was 47 years and 56% were women. Groups 2 and 3 were more frequently referred for genetic consultation than group 1, 73%, and 94% versus 26% (P < 0.001). A total of 67% followed up on the referral. The prevalence of genetic mutation was 50% (21/42 tested). The percentage with a genetic syndrome was 23%, 28%, and 22% respectively for groups 1, 2, and 3.Conclusions: Referral for genetic counseling significantly increased in the past 15 years. However, only two‐thirds of patients followed up with genetic counselors and, therefore, clinicians can do more to improve the adherence rate for genetic counseling.
- 8 January 2018
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (6) , 1217-1222
Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15‐year experience in a high‐volume tertiary referral center
Background and Objectives: Genetic testing for pheochromocytoma and paraganglioma allows for early detection of hereditary syndromes and enables close follow‐up of high‐risk patient. We investigated the trends in genetic testing among patients at a high‐volume referral center and evaluated the prevalence of pheochromocytomas and paragangliomas.Methods: We reviewed the charts of 129 patients who underwent adrenalectomy for pheochromocytoma and paraganglioma between January 2000 and July 2015. To evaluate for trends in genetic testing, patients were divided by year of diagnosis: 2000‐2005 (group 1, n = 35), 2006‐2010 (group 2, n = 44), and 2011‐2015 (group 3, n = 50).Results: Among 129 patients the mean age was 47 years and 56% were women. Groups 2 and 3 were more frequently referred for genetic consultation than group 1, 73%, and 94% versus 26% (P < 0.001). A total of 67% followed up on the referral. The prevalence of genetic mutation was 50% (21/42 tested). The percentage with a genetic syndrome was 23%, 28%, and 22% respectively for groups 1, 2, and 3.Conclusions: Referral for genetic counseling significantly increased in the past 15 years. However, only two‐thirds of patients followed up with genetic counselors and, therefore, clinicians can do more to improve the adherence rate for genetic counseling.